The drug "Vigamox" (eye drops). Instructions

Pharmaceutical preparation "Vigamox" (eye drops), instruction for use reports, has an international non-proprietary name moxifloxacin.

One milliliter of this medication contains 5.45 milligrams of moxifloxacin hydrochloride, and the additional components are sodium chloride, boric acid, hydrochloric acid and purified water.

The drug is a clear liquid, the color of which is greenish-yellow.

The systemic absorption of the active active ingredient is fixed when using the drug "Vigamox" (eye drops). The instruction indicates that the half-life period is about thirteen hours.

Moxifloxacin belongs to the third generation of fluoroquinolone antibiotics. It is active against a large number of both gram-negative and gram-positive bacteria, anaerobes and atypical pathogenic microorganisms.

The drug "Vigamox" (eye drops) instructions for use recommend the use of local therapy for conjunctivitis of bacterial origin. This drug should be instilled in the affected organ of vision , one drop two or three times a day. Duration of treatment - four days (on average). It is noted that it is extremely undesirable to touch the tip of the pipette used to the eye or other surface, otherwise the medicinal contents of the vial may be contaminated.

Medication "Vigamox" - eye drops, used even for newborns. However, they should be used with caution, since side effects include temporary discomfort, decreased vision, dry eyes, itching, keratitis and subconjunctival hemorrhages.

The drug "Vigamox" (eye drops), the instruction includes this information, can also cause the development of systemic undesirable effects such as swallowing of the pharynx (and also larynx, face), collapse of the cardiovascular system, headaches, fainting, pharyngitis, respiratory Insufficiency, utricuria.

The drug "Vigamox" is a drop, the main active substance of which does not interact with theophylline, digoxin, or with intraconazole. In addition, it can be taken in parallel with oral contraceptives.

It should be taken into account that prolonged use of the drug in question (as well as any other antibiotic) can lead to excessive growth of insensitive microorganisms. With the development of superinfection, the use of the drug should be discontinued and alternative ways of treating the disease should be addressed.

The drug for women waiting for a child is not contraindicated, however, its appointment should be carried out exclusively by a specialist (not independently). In addition, this drug is administered with special care to nursing mothers, since there is insufficient information about the penetration of moxifloxacin into breast milk.

When treating bacterial conjunctivitis, the patient should not install contact lenses until the symptoms disappear completely.

Since after the application of these drops, temporary blurred vision or other visual discomfort is not excluded, from control of the car or potentially dangerous mechanisms during the period of therapy should be avoided.

Overdosage of the drug is not possible due to the limited capacity of the conjunctival sac. Intoxication is also excluded after unintentional ingestion of droplets.

Shelf life of the medication is thirty months. After the opening of the factory packaging - four weeks.